Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Scherle Peggy
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
02/09/2023
4
Scherle Peggy (Chief Scientific Officer) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
Granted 135,000 options to buy @ $7.2, valued at $972k
02/17/2022
4
Scherle Peggy (Chief Scientific Officer) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
Granted 100,000 options to buy @ $10.58, valued at $1.1M
08/30/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
04/09/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
09/24/2020
3
Scherle Peggy (Chief Scientific Officer) has filed a Form 3 on Prelude Therapeutics Inc
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy